Source:http://linkedlifedata.com/resource/pubmed/id/19161453
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2009-1-23
|
pubmed:abstractText |
Robenacoxib is a new nonsteroidal anti-inflammatory drug (NSAID) developed for use in companion animal medicine. The objectives of this study were: to quantify the inhibitory actions of robenacoxib on cyclooxygenase (COX) isoenzymes in feline whole blood assays; to establish blood concentration-time profiles of robenacoxib after intravenous and subcutaneous dosing in the cat and; to predict the time courses of inhibition of COX isoforms by robenacoxib. COX-1 and COX-2 activities in heparinized feline whole blood samples were induced with calcium ionophore and lipopolysaccharide, respectively. Inhibition of thromboxane B2 provided a marker of both COX-1 and COX-2 activities and a nonlinear parametric mixed effects modelling approach was used to establish the pharmacodynamic parameters describing this inhibition. Mean values (and prediction intervals) of IC50 were 28.9 (16.4-51.1) microM (COX-1) and 0.058 (0.010-0.340) microM (COX-2). These parameters were used to compute several selectivity indices. Selectivity IC ratios (COX-1:COX-2) were 502.3 (IC50/IC50), 451.6 (IC95/IC95) and 17.05 (IC20/IC80). Based on a clinically recommended dosage regimen of 2 mg/kg, it was predicted that the corresponding mean robenacoxib blood concentration over the first 12 h after drug administration corresponded to 5% inhibition of COX-1 and 90% inhibition of COX-2.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Anti-Inflammatory Agents...,
http://linkedlifedata.com/resource/pubmed/chemical/Cyclooxygenase 1,
http://linkedlifedata.com/resource/pubmed/chemical/Cyclooxygenase 2,
http://linkedlifedata.com/resource/pubmed/chemical/Cyclooxygenase 2 Inhibitors,
http://linkedlifedata.com/resource/pubmed/chemical/Cyclooxygenase Inhibitors,
http://linkedlifedata.com/resource/pubmed/chemical/Isoenzymes,
http://linkedlifedata.com/resource/pubmed/chemical/Thromboxane B2
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
1365-2885
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
32
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
31-40
|
pubmed:meshHeading |
pubmed-meshheading:19161453-Animals,
pubmed-meshheading:19161453-Anti-Inflammatory Agents, Non-Steroidal,
pubmed-meshheading:19161453-Area Under Curve,
pubmed-meshheading:19161453-Cats,
pubmed-meshheading:19161453-Cyclooxygenase 1,
pubmed-meshheading:19161453-Cyclooxygenase 2,
pubmed-meshheading:19161453-Cyclooxygenase 2 Inhibitors,
pubmed-meshheading:19161453-Cyclooxygenase Inhibitors,
pubmed-meshheading:19161453-Dose-Response Relationship, Drug,
pubmed-meshheading:19161453-Female,
pubmed-meshheading:19161453-Inhibitory Concentration 50,
pubmed-meshheading:19161453-Injections, Intravenous,
pubmed-meshheading:19161453-Injections, Subcutaneous,
pubmed-meshheading:19161453-Isoenzymes,
pubmed-meshheading:19161453-Male,
pubmed-meshheading:19161453-Thromboxane B2
|
pubmed:year |
2009
|
pubmed:articleTitle |
Differential inhibition of cyclooxygenase isoenzymes in the cat by the NSAID robenacoxib.
|
pubmed:affiliation |
Department of Veterinary Basic Sciences, Royal Veterinary College, Hertfordshire, UK.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|